Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus.
about
Immunogenetic mechanisms driving norovirus GII.4 antigenic variationVaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio choleraeNorovirus immunology: Of mice and mechanismsSeroepidemiology of norovirus-associated travelers' diarrheaNorovirus drug candidates that inhibit viral capsid attachment to human histo-blood group antigens.Antiviral targets of human norovirusesEpidemiology of human noroviruses and updates on vaccine developmentDevelopment of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis.Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activityLlama nanoantibodies with therapeutic potential against human norovirus diarrhea.Serological Correlates of Protection against a GII.4 Norovirus.Correlates of Protection against Norovirus Infection and Disease-Where Are We Now, Where Do We Go?Frequent Use of the IgA Isotype in Human B Cells Encoding Potent Norovirus-Specific Monoclonal Antibodies That Block HBGA Binding.Static and Evolving Norovirus Genotypes: Implications for Epidemiology and Immunity.Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectivesNorovirus vaccine development: next steps.Norovirus vaccines: Correlates of protection, challenges and limitationsReplication of Human Norovirus RNA in Mammalian Cells Reveals Lack of Interferon Response.Determination of the 50% human infectious dose for Norwalk virus.Noroviruses and histo-blood groups: the impact of common host genetic polymorphisms on virus transmission and evolution.Noroviruses: epidemiology, immunity and prospects for prevention.Prospects and Challenges in the Development of a Norovirus Vaccine.Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization.Development of a Surrogate Neutralization Assay for Norovirus Vaccine Evaluation at the Cellular Level.Sequential Gastroenteritis Outbreaks in a Single Year Caused by Norovirus Genotypes GII.2 and GII.6 in an Institutional Setting
P2860
Q24810360-6FFA5900-5F72-43A4-AFB1-EADE52C51DFDQ27004488-C70E0816-1B74-4510-9D91-6231D192BF18Q28083087-6C3C9413-7E4B-4AC7-B284-3E51B0551D61Q28395024-C57C2A60-A39E-47CD-A408-62C439A3FD0EQ30248992-52A09B6C-24E7-4D58-9F0E-3FB9443AB174Q30249527-538023EB-007C-46C2-A8D0-4768AB4547D0Q34385139-7C87B7A1-47CA-4194-BEFC-ABA01D1437C4Q34778430-301206D3-B325-4400-8FB4-9DDA5B833467Q35021149-F45C5093-5705-417E-B06E-22358A531F80Q35744232-26DDE2E2-2719-418C-ABB6-BE978C218CBAQ35901978-7EE1A3CF-D6C7-4246-B6A0-BDC2A97E779EQ35999334-9D549E9A-B1E6-468B-839F-E12E0BB1E64CQ36063949-AE04E5C3-F464-4DC2-84D9-4C98A91846ACQ36254157-11F77D38-C097-4A95-9326-0C5809C88413Q36275589-1072D974-9EA3-4F79-A6CB-98A142CC72A5Q37133116-BE01050D-2921-47B3-8F03-44EB91A53DF4Q37135476-15863D77-5C04-4275-A06A-71900710A423Q37252978-2A43F2E4-8154-40E4-997C-B6C01D55B6C6Q37635146-428AA929-5304-418A-8F75-302F6FD862C8Q38130186-DE748191-D44A-4EDE-AF01-2E1D627C5748Q38322750-636425A9-8BC1-43CE-9326-AB926F67BB7EQ40102851-21FE965E-EC1B-4CAE-A0DA-785EEB6E9C9CQ44611786-2B0AA27C-D361-4777-9ABF-CB9748410285Q47557837-620CA4D2-0A54-4BEE-A6FB-2180CAD4B401Q57826949-747F912E-D4A1-4266-AAF6-B28CC921E25D
P2860
Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Serum hemagglutination inhibit ...... s infected with Norwalk virus.
@ast
Serum hemagglutination inhibit ...... s infected with Norwalk virus.
@en
type
label
Serum hemagglutination inhibit ...... s infected with Norwalk virus.
@ast
Serum hemagglutination inhibit ...... s infected with Norwalk virus.
@en
prefLabel
Serum hemagglutination inhibit ...... s infected with Norwalk virus.
@ast
Serum hemagglutination inhibit ...... s infected with Norwalk virus.
@en
P2093
P2860
P50
P356
P1476
Serum hemagglutination inhibit ...... s infected with Norwalk virus.
@en
P2093
Antone R Opekun
Mark A Gilger
Rita Czakó
P2860
P304
P356
10.1128/CVI.05592-11
P577
2011-12-21T00:00:00Z